Dr. McIntosh, CEO at Neurasic, is a biotech R&D leader with 15+ years experience in the development and commercialization of innovative biological products and services for human health and agriculture. She has significant expertise in driving science and product development strategies, managing academic and industrial scientific collaborations, and intellectual property creation and management. Most recently, Laura was the Vice President R&D at Concentric AG where she was responsible for the science and IP strategy in the development of commercially viable microbial-based products for the soil microbiome. As Vice President, Translational Research at Caprion Biosciences, she was responsible for the scientific integrity and oversight of all client-based proteomics projects. She also co-led of a large public-private personalized medicine project in the province of Quebec. Laura has also held senior-level positions at Osprey Pharmaceuticals Ltd where she led the research and clinical trials of a platform of protein therapeutic drugs, and at ART Advanced Research Technologies where she was involved in the development and commercialization of an optical imaging device.
After completing her doctorate in human anatomy and cell biology at the University of Manitoba, Dr. McIntosh was awarded an NSERC post-doctoral fellowship at the National Research Council of Canada. Laura also holds a Master of Science in Human Anatomy and Cell Science from the University of Manitoba, and a Bachelor of Science in Zoology from Brandon University in Brandon, Manitoba. She has numerous peer reviewed publications in the fields of muscle regeneration, oncology, renal disease and biomarker identification.